Trends in the total numbers of HBV and HCV carriers in Japan from 2000 to 2011.
Junko TanakaT AkitaM OhisaK SakamuneK KoS UchidaM SatakePublished in: Journal of viral hepatitis (2018)
We estimated the total number of undiagnosed HBV and HCV carriers and patients with hepatitis virus-related disease in Japan according to 6 different groups classified by their natural histories during 2011. In 2011, the total number of carriers and patients infected with HBV or HCV was estimated according to 6 groups using government reports and reports from the hepatitis epidemiology research group of The Ministry of Health, Labor and Welfare in Japan. In 2011, the total number of hepatitis virus carriers was estimated to be 2 090 128-2 840 128 in which the estimated number of undiagnosed HCV and HBV carriers was 776 826 (HBV: 481 470; HCV: 295 356). The total number of treated patients, as either inpatients or outpatients, was estimated to be 811588 (HBV: 303 366; HCV: 520 600) in 2011. It is presumed that many carriers shirk consultation for many reasons, such as patients' misunderstanding, lack of awareness and forgetfulness of their positive status. The numbers of infected patients who did not seek treatment increased gradually to 501 714-1 251 714 (HBV: 333 791-483 791; HCV: 167 923-767 923) in 2011. Compared to 2000, the number of undiagnosed carriers was significantly reduced in 2011 probably because of the well-organized, effective national hepatitis virus screening system that has been launched by the Japanese government since 2002. Moreover, the increase in the number of untreated persons who are aware of their positive status shows that more effort should be invested in improving the referral system from screening centres to core hospitals.
Keyphrases
- hepatitis b virus
- hepatitis c virus
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- liver failure
- healthcare
- prognostic factors
- peritoneal dialysis
- human immunodeficiency virus
- public health
- mental health
- risk assessment
- risk factors
- palliative care
- combination therapy
- social media
- human health
- antiretroviral therapy